Governor Newsom signed into law Senate Bill 41 materially reshaping the regulation of pharmacy benefit management, reimbursement,...
Reed Smith LLP
On Nov. 8, 2023, the Senate Finance Committee voted 26-0 to approve the Better Mental Health, Lower Cost Drugs, and Extenders Act. Among...
Earlier this month, in response to the end of the COVID-19 public health emergency, the Department of Health and Human Services (“HHS”)...
On April 18, 2023, the U.S. Department of Health and Human Services (“HHS”) announced its plan to maintain access to COVID-19 vaccines...
On April 7, 2023, only minutes apart, two federal district courts issued rulings on cases challenging the Food and Drug Administration’s...
The Department of Health and Human Services (“HHS”) has proposed a rule that updates retail pharmacy standards for electronic...
In an opinion authored by Justice Samuel Alito and joined by four of the other conservatives, The Supreme Court in Dobbs v. Jackson...
Now that U.S. Supreme Court has overturned Roe v. Wade in Dobbs v. Jackson Women’s Health, the implications of that action will be far...
As noted in an earlier post here, the U.S. Supreme Court is expected to issue an opinion in the Dobbs v. Jackson Women’s Health case...
On June 7, 2022, the Federal Trade Commission (FTC) announced that it would conduct an inquiry into the competitive impact of contracting...
In the first advisory opinion of 2022, the Department of Health and Human Services’ Office of Inspector General (OIG) allowed Medicaid...
On August 12, 2021, the Seventh Circuit joined the Third, Eighth, Ninth, and D.C. Circuits in holding that the “objective reasonableness”...
The Department of Health and Human Services (HHS) has modified HIPAA retail pharmacy transaction requirements to differentiate between...